Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Momenta Pharmaceuticals Inc
Momenta Pharmaceuticals Inc A Massachusetts Corporation

Momenta Pharmaceuticals Inc patents


Recent patent applications related to Momenta Pharmaceuticals Inc. Momenta Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Momenta Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Momenta Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Momenta Pharmaceuticals Inc-related inventors


Fcrn antibodies and methods of use thereof

The present invention features antibodies that have high binding affinity to human neonatal Fc receptor (FcRn). These anti-FcRn antibodies are useful, e.g., to promote clearance of autoantibodies in a subject, to suppress antigen presentation in a subject, to block an immune response, e.g., block an immune complex-based activation of the... Momenta Pharmaceuticals Inc

Control of copolymer compositions

... Momenta Pharmaceuticals Inc

Modified glycoproteins

Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.... Momenta Pharmaceuticals Inc

Modified glycoproteins

Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.... Momenta Pharmaceuticals Inc

Methods of cell culture

Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using ammonium and/or lysine, are described.... Momenta Pharmaceuticals Inc

Methods of cell culture

Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using putrescine, are described.... Momenta Pharmaceuticals Inc

Methods of cell culture

Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using DMSO, are described.... Momenta Pharmaceuticals Inc

Multi-dimensional chromatographic methods for separating n-glycans

A multi-dimensional chromatographic method for the separation of N-glycans. The method comprises providing a glycan preparation that includes at least one negatively charged N-glycan. The glycan preparation is then separated by anion-exchange chromatography and at least one secondary chromatographic technique.... Momenta Pharmaceuticals Inc

Methods of administering lmwh

Methods of treating cancer comprising administering a LMWH.... Momenta Pharmaceuticals Inc

Methods related to biologics

The present invention relates to the characterization and production of biosimilars.... Momenta Pharmaceuticals Inc

Methods related to biologics

The present invention relates to the characterization and production of biologics.... Momenta Pharmaceuticals Inc

Methods and compositions for the diagnosis and treatment of kawasaki disease

The present invention relates to the determination of levels or expression of particular biomarkers in biological samples which can be utilized to diagnose, prognose, and treat Kawasaki disease in subjects, and further to select subjects who would benefit from a Kawasaki disease therapy other than, or in addition to, IVIG... Momenta Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Momenta Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Momenta Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###